Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Beta-Glucans Is a Potential Inhibitor of Ovarian Cancer: Based on Molecular and Biological Aspects Publisher Pubmed



Sadoughi F1 ; Asemi Z1 ; Hallajzadeh J2 ; Mansournia MA3 ; Yousefi B4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
  2. 2. Department of Biochemistry and Nutrition, Research Center for Evidence-Based Health Management, Maragheh University of Medical Sciences, Maragheh, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  5. 5. Department of Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Current Pharmaceutical Biotechnology Published:2022


Abstract

Ovarian cancer is a lethal type of cancer which is initiated to the ovaries and affects 1 out of every 75 women. Due to the high number of deaths (almost 152,000) related to this cancer, it seems that novel efficient therapeutic methods are required in this field. Beta-glucans are a type of glucose linear polymers which have been proven to have a lot of advantageous activities. Recently, investigations have declared that these polysaccharides have the potential to be used as anti-cancer drugs. These agents are able to affect several mechanisms such as inflammation and apoptosis, and that is how cancers are prone to be affected by them. In this review, we attempt to investigate the role of beta-glucans on ovarian cancer. We hope that this paper would give some novel insights into the field of ovarian cancer treatment. © 2022 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Ovarian Cancer in the World: Epidemiology and Risk Factors, International Journal of Women's Health (2019)
2. Fungal Β-Glucans: Biological Properties, Immunomodulatory Effects, Diagnostic and Therapeutic Applications, Infectious Diseases and Clinical Microbiology (2025)
3. Modulation of Apoptosis by Melatonin for Improving Cancer Treatment Efficiency: An Updated Review, Life Sciences (2019)
4. Non-Coding Rnas and Brain Tumors: Insights Into Their Roles in Apoptosis, Frontiers in Cell and Developmental Biology (2022)
5. Gata3 Expression in Tumor-Infiltrating Mononuclear Inflammatory Cells Is Associated With Poor Prognostic Factors in Tubo-Ovarian Carcinomas, Pathology International (2024)
6. Gynecologic Cancers and Non-Coding Rnas: Epigenetic Regulators With Emerging Roles, Critical Reviews in Oncology/Hematology (2021)
7. Effect of Cholestasis and Neuroaid Treatment on the Expression of Bax, Bcl-2, Pgc-1Α and Tfam Genes Involved in Apoptosis and Mitochondrial Biogenesis in the Striatum of Male Rats, Metabolic Brain Disease (2020)
8. Electrochemical Sensors and Biosensors Based on the Use of Polyaniline and Its Nanocomposites: A Review on Recent Advances, Microchimica Acta (2019)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Hamid Reza Mirzaei (2)
Other Related Docs
9. Strong Evidences of the Ovarian Carcinoma Risk in Women After Ivf Treatment: A Review Article, Iranian Journal of Public Health (2019)
10. Overview of Apoptosis, Autophagy, and Inflammatory Processes in Toxoplasma Gondii Infected Cells, Pathogens (2023)
11. Cell Death Pathways and Viruses: Role of Micrornas, Molecular Therapy Nucleic Acids (2021)
12. Signaling Pathways Involved in Cell Cycle Arrest During the Dna Breaks, DNA Repair (2021)
13. Functions, Mechanisms, and Clinical Applications of Lncrna Linc00857 in Cancer Pathogenesis, Human Cell (2023)
14. Association of Polymorphisms in Nucleotide Excision Repair Pathway Genes With Susceptibility to Cutaneous Melanoma; [Vztah Mezi Polymorfizmy Genu Nukleotidove Excizni Reparace a Nachylnosti Ke Koznimu Melanomu], Klinicka Onkologie (2021)
15. Various Concentrations of Hesperetin Induce Different Types of Programmed Cell Death in Human Breast Cancerous and Normal Cell Lines in a Ros-Dependent Manner, Chemico-Biological Interactions (2023)
16. Novel Perspectives for the Diagnosis and Treatment of Gynecological Cancers Using Dysregulation of Piwi Protein and Pirnas As Biomarkers, Current Medicinal Chemistry (2024)
17. Vaccines, Adjuvants, and Delivery Systems, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
18. Development of a Bioluminescence Assay for Bir2- Caspase3 Interaction Through Split Luciferase Complementary Assay, Biochemical Engineering Journal (2022)
19. Vaccines, Adjuvants, and Delivery Systems, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
20. Curcumin Anti‐Tumor Effects on Endometrial Cancer With Focus on Its Molecular Targets, Cancer Cell International (2021)
21. Sensitive and Cost-Effective Tools in the Detection of Ovarian Cancer Biomarkers, Analytical Science Advances (2024)
22. Silibinin Exerts Anti-Cancer Activity on Human Ovarian Cancer Cells by Increasing Apoptosis and Inhibiting Epithelial-Mesenchymal Transition (Emt), Gene (2022)